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Systematized reporter assays 
reveal Zic protein regulatory 
abilities are Subclass‑specific 
and dependent upon transcription 
factor binding site context
Jehangir n. Ahmed1, Koula e. M. Diamand1, Helen M. Bellchambers1,2 & Ruth M. Arkell1*
The ZIC proteins are a family of transcription regulators with a well‑defined zinc finger DNA‑binding 
domain and there is evidence that they elicit functional DnA binding at a Zic DnA binding site. 
Little is known, however, regarding domains within Zic proteins that confer trans-activation or 
-repression. to address this question, a new cell-based trans-activation assay system suitable for Zic 
proteins in HEK293T cells was constructed. This identified two previously unannotated evolutionarily 
conserved regions of ZIC3 that are necessary for trans‑activation. These domains are found in all 
Subclass A Zic proteins, but not in the Subclass B proteins. Additionally, the Subclass B proteins fail 
to elicit functional binding at a multimerised Zic DnA binding site. All Zic proteins, however, exhibit 
functional binding when the Zic DnA binding site is embedded in a multiple transcription factor locus 
derived from Zic target genes in the mouse genome. this ability is due to several domains, some of 
which are found in all Zic proteins, that exhibit context dependent trans-activation or -repression 
activity. this knowledge is valuable for assessing the likely pathogenicity of variant Zic proteins 
associated with human disorders and for determining factors that influence functional transcription 
factor binding.
The Zic genes encode a family of multi-functional transcription regulators required for a diverse range of bio-
logical processes in embryogenesis and adult  homeostasis1,2. The defining feature of the corresponding proteins 
(ZIC1, ZIC2, ZIC3, ZIC4 and ZIC5) is a zinc finger domain (ZFD) composed of five tandem Cys2His2 (C2H2)-
type zinc fingers (ZFs). The ZFD is most closely related to the GLI, GLIS and NKL families but the ZIC ZFD is 
distinguished by an atypical first ZF. Generally, one to five amino acids separate the two cysteines of a C2H2 ZF 
but, in the first ZF of ZIC proteins in species so far examined, this number ranges from 6 to  383. In addition, the 
first two ZFs of ZIC proteins contain a tryptophan residue between the canonical cysteines and structural analysis 
suggests these two ZFs may form a single structural unit called a CWCH2  motif3,4. The ZIC ZFD was one of the 
first shown to participate in both DNA binding and protein  binding5 and this dual capability contributes to the 
myriad molecular roles of ZIC proteins (reviewed  in6). Outside of the ZFD, phylogenetic analysis has identified 
two other regions conserved amongst ZIC proteins. The N-terminal ZOC box is found within ZICs 1, 2 and 
 33 and participates in protein–protein  interactions7,8. Just N-terminal of the ZFD there is another short, highly 
conserved sequence, called the ZFNC, which is of unknown function. Each of the ZIC proteins also contain low 
complexity regions, including stretches of Alanine (ZICs 1, 2, 3, 4 and 5), Histidine (ZICs 1, 2 and 3), as well as 
Serine/Glycine (ZICs 2 and 5) and Proline (ZIC5)2.
On the basis of protein sequence conservation, ZIC proteins are classified into two Subclasses: Subclass A 
proteins (ZICs 1, 2 and 3) share a conserved ZFD and contain the N-terminal ZOC box, whereas the Subclass 
B proteins (ZIC4 and 5) have a divergent first ZF and lack the ZOC box. The Subclass division has its basis in 
invertebrate evolution where a single ancestral Zic gene underwent tandem duplication and divergence prior to 
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the genome duplications early in the vertebrate  lineage2,3. Many vertebrate Zic genes therefore still exist as diver-
gently transcribed, tandem pairs. For example, in the teleost lineage zic1 and zic4 form a gene pair as do zic2/zic5 
and zic3/zic69. The zic6 gene has been lost from tetrapods and the precursor to the mammalian X-chromosome 
underwent a deletion/inversion event such that zic6 was lost and the orientation of the zic3 gene was reversed. 
Consequently, in mammals ZIC1/ZIC4 and ZIC2/ZIC5 remain as gene pairs whereas ZIC3 is an X-linked sin-
gleton. A corollary of the gene-pair arrangement is that Zic1 and Zic4 as well as Zic2 and Zic5 have extensive 
overlap in expression domains in multiple  organisms9–13. Exactly how these sequence differences influence the 
function of the distinct Subclass proteins is unknown.
A significant impediment to understanding the sequence/function relationships for ZIC proteins is the short-
age of robust cell-based reporter assays. Such assays have been difficult to generate because ZIC proteins produce 
high background in the reporter assays tested to date; an effect attributed to their ability to stimulate a range of 
widely used basal promoters (such as TK and SV40). ZIC expression can therefore lead to false positive effects 
at reporter constructs driven by these  promoters14 and can cross-regulate plasmids designed to normalise for 
transfection efficiency  differences15. Other features contributing to the dearth of ZIC specific cell-based assays 
are the poor specificity and/or strength of commercially available antibodies,as well as the lack of non-DNA 
interacting ZIC variant proteins and in vitro validated DNA binding elements (or ZIC response elements,ZREs). 
Initial attempts to identify a consensus ZIC DNA binding site used yeast one-hybrid16,17 or cDNA  selection14 
approaches, one of which identified ZIC protein binding sites on the APOE promoter. This element remains the 
most commonly employed promoter for ZIC trans-activation  assays15,17,18. There is however no evidence that 
APOE is an in vivo ZIC target and during early murine embryonic development, when ZIC proteins are most 
active, the Apoe gene and Zic genes are not co-expressed12,19. More recent  experiments20,21 identify a different ZIC 
binding sequence to that identified at the APOE promoter or in previous  experiments14,16. The consensus ZIC3 
DNA-binding motif identified independently by both protein binding  microarray20 and ChIP-chip  experiments21 
is  CCC/TGCT GGG . Murine ZIC3 binds this site at the Nanog proximal promoter and directs expression of 
Nanog21, a pluripotency gene that is co-expressed with Zic3 during early murine  development12,22. In this con-
text, ZIC3 exhibits functional DNA binding, i.e. ZIC3 both binds DNA and elicits a transcriptional response.
Here we have addressed issues associated with cell-based ZIC reporter assays by constructing a suite of 
reporter and expression constructs optimised for interrogating the trans-activation ability of ZIC proteins in 
HEK293T cells. A vector backbone and basal promoters refractory to ZIC activation were identified and it was 
shown that ZREs are not subjected to high stimulation by endogenous TFs in HEK293T cells. The ZIC compatible 
vector was used to build reporter constructs that contain either the multimerised ZIC3 site identified in Badis, 
et al.20 and Lim, et al.21 or recently identified ZIC-specific genomic targets. Additionally, a suite of ZIC expression 
constructs (each with an N-terminal epitope tag for co-ordinated detection) were built and a variant of each ZIC 
protein generated that cannot interact with reporter DNA. This systematized group of reporter and expression 
constructs enable comparison between ZIC family members and test ZREs in a ‘one variable at a time’ manner. 
This system demonstrates for the first time that trans-activational abilities of the two ZIC Subclasses are different. 
The Subclass A proteins drive high levels of transcription at the identified ZIC consensus binding site in isola-
tion, whereas the Subclass B proteins do not. The trans-activation ability of ZIC3 maps to two newly identified 
domains that are evolutionarily conserved amongst Subclass A, but not Subclass B ZICs. When, however, the ZIC 
binding site is co-located with other transcription factor binding sites (TFBS) in a multiple transcription factor 
locus (MTL), all ZIC proteins are able to stimulate transcription, and this ability requires ZIC/DNA interaction. 
In addition to the trans-activation domains, the ZIC3 protein contains several domains, some of which are found 
amongst all ZIC proteins, which act in a context dependent manner to regulate transcription. The activity of a 
ZIC protein at a ZRE is therefore determined by its particular complement of transcriptional regulatory domains 
and the co-location of other TFBS at the genomic locus.
Results
Wildtype and non-reporter-DnA-interacting variant Zic proteins. To generate wildtype ZIC pro-
teins, a cDNA corresponding to each human ZIC protein was cloned into the same vector (V5-DEST) to enable 
production of N-terminally V5 epitope tagged proteins following transfection in mammalian cell lines. The use 
of the same vector backbone and an epitope tag facilitates meaningful comparison of different ZIC proteins in 
transfections, reporter assays and western blot/antibody hybridisation procedures. In reporter assays, signal is 
generated when the overexpressed protein binds a test DNA element contained within the reporter construct 
and elicits transcription. Several non-specific activities can confound interpretation of these assays, for example, 
luciferase activity could be stimulated by (non ZIC) endogenous transcription factors acting on cryptic DNA 
binding sites in the plasmid. To distinguish between these possibilities, negative control ZIC protein variants 
that do not interact with the reporter plasmid DNA are required. Since a missense mutation affecting a key 
cysteine residue in the 4th ZF of ZIC2, that causes the C370S amino acid substitution, eliminates DNA bind-
ing  ability15, an orthologous substitution was made in cDNAs encoding each of the four remaining human ZIC 
proteins (Fig. 1A). These were tested by plasmid-IP-qPCR (pIP; a modified version of ChIP-qPCR using plasmid 
DNA) following co-transfection of expression plasmids and reporter constructs containing a known ZRE. Each 
expression vector (wildtype and mutant) was also co-transfected with the negative control empty parent reporter 
construct (pGL4.20 designated B:Luc2). Each ZIC mutant displayed significantly reduced enrichment at the 
ZRE relative to the corresponding wildtype protein (Fig. 1B–F). In all cases (ZIC1-5) the ZIC mutant protein 
reduced ZRE interaction to levels less than or equivalent to that shown with the negative control plasmid (data 
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Figure 1.  A new trans-activation assay for ZIC proteins. (A) Schematic representation of the missense mutation [second 
cysteine (C) converted to serine (S)] introduced into each ZIC protein. (B–F) qPCR (N = 3) output following pIP from 
HEK293T cells co-transfected with the reporter construct (above line) and expression constructs (below line) shown. 
Error bars represent SD between three repeats, *p < 0.01 t-Test. (G–J) HEK293T cells were co-transfected with the reporter 
constructs (above line) and expression constructs (below line) shown. V5-DEST was also co-transfected with each reporter 
construct to measure background (not shown in panels H and J, see Fig. S1 for all data). For each transfection, luminescence 
was measured 24 h post-transfection in each of three replicate samples and each transfection repeated three times (N = 3). 
In each panel, the top graph (G–J) shows one representative experiment with the corresponding western blot. Error bars 
represent the SD between the three replicates. Expression of transfected proteins was confirmed with α-V5 and the α-TBP blot 
served as nuclear fraction loading control. Although cropped blots were used, the gels were run under the same experimental 
conditions. The bottom graph (G′–J′) shows the mean RLA (normalised to V5-DEST such that the V5-DEST value becomes 
1; not shown in H′ and J′) value from three independent repeats, Error bars represent SEM. *p < 0.01 ANOVA.
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A robust and sensitive ZIC3 transcription assay. The reporter construct most often used in cell-
based ZIC trans-activation assays consists of a genomic fragment from the human APOE promoter (− 189/+ 1) 
cloned into the promoterless pXP2 vector containing the Photinus pyralis luciferase  cDNA17, referred to here as 
B:luc+:APOE. In contrast to pXP2, a range of new generation vectors have been developed in which cryptic DNA 
binding sites for endogenous transcription factors are minimised and the luciferase cDNA codon-optimized 
for expression in mammalian  systems23. To establish a trans-activation assay suitable for dissecting ZIC pro-
tein function, the APOE promoter fragment was transferred to a new generation vector backbone pGL4.20 
(B:luc2) producing B:luc2:APOE. For direct comparison, the B:luc+:APOE and B:luc2:APOE reporter constructs 
were transfected into HEK293T cells with either an empty expression vector (V5-DEST), V5-tagged wildtype 
ZIC3 (V5-ZIC3-wt) or the V5-tagged non-DNA-interacting form of ZIC3 (V5-ZIC3-C365S). Although the 
B:luc2:APOE displayed similar background levels to B:luc+:APOE (i.e. in the presence of V5-DEST), there was 
a significant increase in ZIC3 dependent luciferase activity from B:luc2:APOE in comparison to B:luc+:APOE. 
Importantly, this difference could be clearly seen when data was expressed relative to the luciferase activity in 
the presence of V5-DEST (to calculate the relative luciferase activity) (Fig. 1G,G′). For both reporter constructs, 
expression of ZIC3-C365S reduced luciferase activity to background levels, indicating the increase in luciferase 
activity in the presence of ZIC3-wt is dependent on interaction with the reporter DNA.
To identify suitable ZREs three sequences were tested: (1) the APOE promoter  fragment17, (2) the Nanog prox-
imal promoter  element21 and, (3) a multimerised (containing six tandem copies) ZIC binding sequence (desig-
nated Z3M2) corresponding to that identified by both protein binding  microarray20 and ChIP-chip  experiments21. 
Each sequence was cloned upstream of the luc2 cDNA in B:luc2 to generate B:luc2:APOE, B:luc2:Nanog and 
B:luc2:Z3M2, respectively. When transfected into HEK293T cells in the presence of V5-ZIC3-wt or V5-ZIC3-
C365S each reporter construct was trans-activated by ZIC3 in a DNA-interaction dependent manner (Figs. 1H, 
S1A) with the APOE promoter fragment driving the highest luciferase activity. When data was expressed relative 
to the luciferase activity at each reporter in the presence of V5-DEST (Fig. 1H′) it became apparent that not all 
signal derived from the APOE promoter fragment was ZIC3 dependent and that other endogenous transcription 
factors contributed to the high luciferase activity in this experiment. In contrast ZIC3 made a significant contri-
bution to the activity at both the Nanog and Z3M2 elements, where the Z3M2 element led to high enrichment 
over the background trans-activation level.
In previous studies the ZIC proteins have been shown to stimulate basal promoters commonly used in het-
erologous expression systems (such as TK and SV40)14 or ZIC protein variants interacted unpredictably with 
co-transfected control plasmids (with TK as promoter)15. In HEK293T cells, the SV40 promoter is strongly stimu-
lated by ZIC proteins (up to 25 fold), whereas the TK promoter led to 4–8-fold  stimulation14. In our experiments 
ZIC3 weakly stimulated the TK promoter (1.4 fold increase) (Fig. 1I,I′), suggesting that previous observations 
involving the TK promoter may be due to other vector elements in the pGL2 vector (in comparison to the pGL4 
vector backbone used here). Two additional promoters (β-globin and c-fos) were tested for trans-activation via 
ZIC3. The β-globin promoter was weakly stimulated while transcription was repressed at the c-fos promoter 
(Fig. 1I,I′). Overall these studies indicated that some basal promoters were compatible with ZIC trans-activation 
studies using the B:luc2 vector in HEK293T cells. To further improve trans-activation via ZREs, a basal promoter 
was included in the reporter construct. The β-globin promoter increased luciferase activity when combined 
with the synthetic Z3M2 enhancer (Figs. 1J,J′, S1B) (unlike the TK and c-fos promoters; see Supplementary 
Fig. S1C–E) and did not react unpredictably with ZIC mutants (Fig. 2A–E). Inclusion of the β-globin promoter 
with the genomic promoters (B:luc2:APOE:β-globin and B:luc2:Nanog:β-globin) did not, however, further elevate 
trans-activation (Figs. 1J,J′, S1B).
The Subclass A and B ZIC proteins have different trans‑activation abilities. The DNA binding 
site sequence used in the Z3M2 construct was identified either in a ZIC3 specific  experiment21, or in a Subclass 
A experiment (i.e. with ZIC1, 2 and 3 proteins)20. The ability of each ZIC protein to trans-activate this motif 
was examined in HEK293T cells. All Subclass A ZIC proteins produced high level, DNA interaction dependent 
trans-activation of the B:luc2:Z3M2:β-globin construct (Figs. 2A–C′, S2). To further confirm that protein bind-
ing at the ZIC3 DNA binding site sequence was responsible for the luciferase activity, the site was mutated in 
all six tandem copies (construct B:luc2:Z3mtt:β-globin), reducing luciferase activity by wildtype ZIC1, 2 or 3 to 
that of the respective non-DNA-interacting mutants. In contrast, the Subclass B ZIC proteins (ZIC4 and 5) drove 
very little luciferase activity from the Z3M2 element (Figs. 2D–E′, S2). In the case of ZIC4, luciferase activity was 
reduced in the presence of the wildtype protein (relative to that of the B:luc2:β-globin construct) and this effect 
was dependent upon interaction with DNA at the Z3M2 motif. The ZIC5 protein had a mild stimulatory effect 
on luciferase activity at the Z3M2 element which was not entirely eliminated by an inability to interact with the 
reporter, although mutation of the Z3M2 site prevented ZIC5 dependent trans-activation suggesting that some 
of the luciferase activity seen in the presence of wildtype ZIC5 is due to endogenous transcription factors. Over-
all the data suggest that the Subclass B ZIC proteins do not exhibit functional binding (i.e. binding which results 
in transcriptional activation) at the ZIC3 motif in isolation.
To examine whether ZIC4 and ZIC5 stimulate transcription from genomic elements a suite of reporter con-
structs, each containing a different MTL, were assayed. Along with B:luc2:APOE and B:luc2:Nanog constructs, a 
ZRE from the murine Foxd3 gene was also cloned into B:luc2 without or with the β-globin promoter to generate 
B:luc2:Foxd3 and B:luc2:Foxd3:β-globin. Upon co-transfection in HEK293T cells of each reporter with ZIC4 
wildtype or its non-DNA-interacting variant, ZIC4 displayed DNA-interacting dependent trans-activation ability 
at the Nanog and Foxd3 elements (Figs. 2G,G′, S2) that was within range of the activity displayed by the subclass A 
ZIC3 protein at the B:luc2:Nanog construct (Figs. 3, 4, 5). The APOE construct again showed non-specific activity 
and the β-globin promoter did not further enhance trans-activation at the Foxd3 element (Figs. 2F–G′, S2). The 
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Figure 2.  Trans-activation spectrum of ZIC proteins. HEK293T cells were co-transfected with the reporter 
constructs (above line) and expression constructs (below line) shown. V5-DEST was also co-transfected with 
each reporter to measure background (not shown, see Fig. S2 for all data). For each transfection, luminescence 
was measured 24 h post-transfection in each of three replicate samples and each transfection repeated three 
times (N = 3). In each panel, the top graph (A–I) shows one representative experiment with the corresponding 
western blot. Error bars represent the SD between the three replicates. Expression of transfected proteins was 
confirmed with α-V5 and the α-TBP or α-Lamin B1 blot served as nuclear fraction loading control. Although 
cropped blots were used, the gels were run under the same experimental conditions. The bottom graph 
(A′–I′) shows the mean RLA value (normalised to V5-DEST such that the V5-DEST value becomes 1; note 
the normalised V5-DEST is not shown) calculated from three independent repeats. Error bars represent SEM. 
*p < 0.01 ANOVA.
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presence of ZIC5 led to similar results, although the fold induction via each element was larger than that for ZIC4 
and the trans-activation at the APOE element was dependent upon ZIC5 interaction with DNA (Figs. 2H–I′, 
S2). Overall it appears that ZIC4 and ZIC5 can act as context dependent transcription factors at MTLs and that 
the binding of other transcription factors at flanking DNA facilitates ZIC4 and ZIC5 trans-activation ability.
The C‑terminus is required for ZIC3 trans‑activation ability. To determine which regions of the 
ZIC3 protein contribute to its trans-activation ability a series of truncated proteins were assayed. The protein 
truncations (Fig. 3A) were designed based on premature termination codon (PTC) containing ZIC3 variants 
associated with Heterotaxy in  humans24,25 or  mice18 and each was missing the C-terminus and either the whole 
ZFD (ZIC3-E155X and ZIC3-katun) or parts of it (ZIC3-C268X, ZIC3-Q292X, ZIC3-1507insTT, ZIC3-K408X). 
Each protein was stably expressed upon transfection of the corresponding plasmid into HEK293T cells (see WBs 
in Fig. 3C,D) and each was able to accumulate within the nucleus, although not always to the same degree as the 
wildtype protein, as assessed by immunofluorescence (see Supplementary Figs. S3 and S4). The ability of each 
protein to trans-activate a ZRE was assessed using the multimerised ZIC3 binding site (B:luc2:Z3M2:β-globin) 
or the Nanog MTL (B:luc2:Nanog). Each protein was unable to trans-activate either reporter (Fig. 3C–D′), fur-
ther confirming the importance of the ZFD and C-terminus.
The most complete of the tested proteins (ZIC3-K408X) truncates at amino acid 408 which lies between the 
two canonical histidines in ZF5 of ZIC3. To distinguish if the inability to trans-activate reporter sequences by this 
protein is due to a defect in ZF5 or lack of the C-terminal domain, ZIC3 proteins with a mutation at the canonical 
cysteine in each ZF were produced (Fig. 3B) and tested in the same assays. Each of these proteins (ZIC3-C268S, 
ZIC3-C302S, ZIC3-C335S, ZIC3-C365S and ZIC3-C393S) is stably expressed in HEK293T cells and localises 
to the nucleus (see Supplementary Figs. S3 and S4). Mutation of ZF1-4 ablates trans-activation ability, whereas 
mutation of ZF5 does not fully eliminate trans-activation ability (Fig. 3E–F′). The contrast between the partial 
Figure 3.  C-terminal regions and ZFD of ZIC3 are required for trans-activation. (A, B) Schematic 
representation of wildtype ZIC3 and (A) PTC-containing mutants or (B) ZF mutants containing a missense 
mutation in the second cysteine (C) [converted to serine (S)]. (C–F) HEK293T cells were co-transfected 
with the reporter construct (above line) and expression constructs (below line) shown. For each transfection, 
luminescence was measured 24 h post-transfection in each of three replicate samples and each transfection 
repeated three times (N = 3). In each panel, the top graph (C–F) shows one representative experiment with the 
corresponding western blot. Error bars represent SD between the three replicates. Expression of the transfected 
proteins was confirmed with α-V5 and the α-LaminB1 (C, D) or α-TBP (E, F) blots served as nuclear fraction 
loading control. Although cropped blots were used, the gels were run under the same experimental conditions. 
The bottom graph (C′–F′) shows mean RLA (normalised to V5-DEST such that the V5-DEST value becomes 1), 
N = 3. Error bars represent SEM. a, b and c: p < 0.01 ANOVA.
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Figure 4.  N-terminal of ZIC3 is required for trans-activation. (A) Schematic representation of the ZIC3 deletion mutants 
used. ZIC3-ZOCdel is missing the ZOC domain (green band); ZIC3-ZFNCdel is missing the ZFNC domain (brown band); 
ZIC3-Ndel is missing the entire N-terminal (amino acids preceding ZF1); ZIC3-Aladel is missing the Alanine tract (orange 
band); and ZIC3-Hisdel is missing the Histidine tract (yellow band). (B–E) HEK293T cells were co-transfected with the 
reporter construct (above line) and expression constructs (below line) shown. For each transfection, luminescence was 
measured 24 h post-transfection in each of three replicate samples and each transfection repeated three times (N = 3). In each 
panel, the top graph (B–E) shows one representative experiment with the corresponding western blot. Error bars represent 
SD between the three replicates. Expression of the transfected proteins was confirmed with α-V5 and the α-TBP blot served 
as nuclear fraction loading control. Although cropped blots were used, the gels were run under the same experimental 
conditions. The bottom graph (B′–E′) shows mean RLA (normalised to V5-DEST such that the V5-DEST value becomes 1), 
N = 3. Error bars represent SEM. a, b, c and d: p < 0.01 ANOVA.
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Figure 5.  Subclass A ZIC proteins contain two evolutionary conserved regions that regulate transcription. (A, B) ZIC protein sequence 
alignment of (A) the N-terminal (SANC) and (B) the C-terminal (SACC) evolutionary conserved regions found in a variety of metazoan 
species: Ap, Asterina pectinifera; Sp, Strongylocentrotus purpuratus; Bf, Branchiostoma floridae; Cj, Corbicula sp.; Sso, Spisula solidissima; 
Lb, Loligo bleekeri; Hs, Homo sapiens; Mm, Mus musculus; Xl, Xenopus laevis; Dr, Danio rerio. Asterick (*) = identical residues. Colon 
(:) = functionally conserved residues. Period (.) = weak conservation of residue. (C) Schematic representation of the ZIC3 deletion 
mutants created. ZIC3-SANCdel is missing the SANC domain; ZIC3-SACCdel is missing the SACC domain. (D, E) HEK293T cells were 
co-transfected with the reporter construct (above line) and expression constructs (below line) shown. For each transfection, luminescence 
was measured 24 h post-transfection in each of three replicate samples and each transfection repeated three times (N = 3). In each panel, 
the top graph (D, E) shows one representative experiment with the corresponding western blot. Error bars represent SD between three 
internal replicates. Expression of the transfected proteins was confirmed with α-V5 and the α-TBP blot served as nuclear fraction loading 
control. Although cropped blots were used, the gels were run under the same experimental conditions. The bottom graph (D′, E′) shows 
mean RLA (normalised to V5-DEST such that the V5-DEST value becomes 1). Error bars represent SEM. a, b, and c: p < 0.01 ANOVA.
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loss of trans-activation by the ZF5 mutant and the total loss shown by ZIC3-K408X indicates that C-terminal 
sequences necessary for trans-activation are located downstream of the ZFD.
Multiple n-terminal domains contribute to the control of Zic-dependent transcription. To 
examine the effect of the N-terminus, a series of deletion mutants were created (Fig. 4A). Each of these proteins 
was stably expressed in HEK293T cells and localised to the nucleus (see Supplementary Figs. S3 and S4). The 
N-terminal deletion (ZIC3-Ndel) was incapable of eliciting transcription from the multimerised ZIC3 binding 
site but drove vast over-stimulation of the Nanog promoter relative to wildtype ZIC3 protein (Fig. 4B–C′). This 
suggests an interaction with other DNA bound proteins at the Nanog promoter enables trans-activation via 
ZIC3-Ndel and in this context the N-terminus has a strong transcriptional repression activity. Specific dele-
tion of the N-terminus conserved domains (ZOC and ZFNC) and the low complexity Histidine repeat region 
(Hisdel) also gave contrasting results at the multimerised and MTL reporter constructs. In each case deletion of 
these domains led to hyper-stimulation of the isolated ZIC3 binding site but either had no effect on or decreased 
transcription at the Nanog promoter (Fig. 4B–E′). Deletion of the low complexity Alanine repeat region (Aladel) 
did not alter trans-activation from the multimerised ZIC3 binding site, but caused a mild reduction in transcrip-
tion at the Nanog promoter. Overall several regions within the N-terminus (the ZOC and ZFNC domains as 
well as the Alanine and Histidine repeats) each appear to be necessary for optimal trans-activation at the Nanog 
promoter, whereas three of these domains (ZOC, ZFNC and Histidine repeat) act as repressive domains at the 
multimerised ZIC3 binding site.
Subclass A‑specific evolutionary conserved domains contribute to trans‑activation. To iden-
tify any other regions of the ZIC3 protein that may contribute to transcriptional control, we conducted a two-
pronged search to find: (1) additional evolutionary conserved regions within the amino acid sequence of all ZIC 
proteins, and (2) regions enriched in amino-acids known to be over-represented in trans-activation domains, 
such as acidic [aspartic acid (D) or glutamic acid (E)], proline (P), glutamine (Q), or serine (S) and threonine (T) 
 residues26. This identified two previously unannotated, evolutionary conserved domains within the Subclass A 
ZIC proteins: (1) a ten amino acid sequence in the N-terminal, referred to here as SANC (Subclass A N-terminal 
Conserved) (Fig. 5A) and since identified as Conserved Domain 3 (CD3) in a thorough search of 121 ZIC pro-
tein sequences from 22 animal  phyla27, and (2) a less-deeply conserved 14 amino acid sequence (nine of which 
are known to be present in trans-activation domains) in the C-terminus, referred to here as SACC (Subclass 
A C-terminal Conserved) (Fig. 5B). The influence of these regions on the trans-activation ability of ZIC3 was 
assessed by interstitial deletion of the respective domains (Fig. 5C). The resulting V5-tagged proteins were stably 
expressed and localised in the nucleus (see Supplementary Figs. S3 and S4). Both domains were necessary for 
ZIC3 stimulated trans-activation either at the Nanog promoter and multimerised site (SANC) or only at the 
multimerised site (SACC) (Fig. 5D–E′).
Discussion
The ZIC family of transcription factors are essential for multiple lineage decisions during embryonic develop-
ment and recent work suggests they play important roles in stem cell  function21,28–30 and their dysregulations 
leads to  cancer31–36. Despite numerous roles in embryonic development and adult homeostasis our knowledge 
regarding protein features that enable ZIC functional diversity is incomplete. In vitro reporter assays remain 
an important mechanism for identifying functional domains within transcription factors, for assessing likely 
pathogenicity of variant proteins and for determining factors that influence functional transcription factor 
 binding37,38. Such comparisons rely on the ability to examine one variable at a time. Here, a systematized suite 
of vectors, in which each expression plasmid and each reporter plasmid has an identical backbone and in which 
reporter plasmids utilise promoters that are refractory to ZIC protein influence in the cell line used, was built. 
This allowed meaningful comparisons of ZIC transcription factor activity across wildtype or variant family 
members and between synthetic and genomic target DNA sequences. A deletion strategy identified regions 
necessary for functional DNA binding in HEK293T cells and demonstrated that the trans-activation activity of 
the ZIC proteins is modular and context dependent. In ZIC3, the trans-activation activity is enhanced by two 
Subclass A-specific, evolutionarily conserved domains (SANC and SACC). The Subclass B proteins lack these 
trans-activation domains and do not produce functional binding at an isolated, but multimerised, ZIC binding 
site. For a further set of domains (the ZOC, ZFNC and low complexity regions), their contribution to ZIC3 trans-
activation ability is context dependent. For example, a domain may decrease trans-activation at the isolated ZIC3 
DNA binding site but promote transcription when the DNA binding site is embedded within a genomic fragment 
that contains multiple transcription factor binding sites (a MTL). The overall ability of each ZIC protein to elicit 
functional binding at a given ZRE is therefore dependent upon both its complement of transcriptional control 
domains and the DNA sequence surrounding the ZRE.
Two complementary studies of ZIC Subclass A binding (a ChIP-chip murine ZIC3 experiment and a protein 
binding  microarray20,21 conducted with the DNA binding domain of ZIC1, ZIC2 and ZIC3) previously identified 
highly similar binding sequences for these proteins. The motif proposed by Lim et al.  (CCC/TGCTG_G) is the 
reverse complement of the secondary motif identified for ZIC1, 2 and 3 by Badis et al. (C_CAGC A/GGG). The 
experiments conducted here experimentally validate this motif for all ZIC proteins and show that functional 
binding of the ZIC Subclass A proteins can occur at this site in isolation or as part of a MTL. The Subclass B 
proteins can interact at this site but trans-activate it only when the site occurs within a MTL. The inability of the 
ZIC Subclass B proteins to elicit functional binding at an isolated, but multimerised, ZIC binding site may be 
because they lack Subclass A-specific trans-activator domains or because the DNA binding site is suboptimal 
for the Subclass B proteins. It would be interesting to determine the relative functional binding activity of each 
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ZIC protein at the other ZIC1-3 binding sites identified by the protein binding microarray study of Badis et al.20 
or to conduct a de novo search for an optimal Subclass B ZIC binding site.
To determine whether the ZIC Subclass A proteins contain trans-activation domains not found in the Subclass 
B proteins, regions of the Subclass A ZIC3 protein required for trans-activation were identified in a classic dele-
tion mapping experiment. All variant proteins tested in the assays were shown to be stably produced and to local-
ise to the cell nucleus. Previous experiments designed to detect homo- or hetero-meric ZIC complexes have not 
found evidence that ZIC proteins co-operate with themselves or other family members to elicit  transcription15. 
Therefore, experiments with a multimerised binding site and overexpressed ZIC3 protein test the effect of protein 
domains on trans-activation free from confounding effects such as DNA accessibility and transcription factor 
co-operativity. When tested in this manner, only the newly identified Subclass A conserved domains SANC and 
SACC are necessary for trans-activation. Other previously identified evolutionarily conserved domains (the ZOC 
and ZFNC domains) behaved as transcriptional repressor domains. Additionally, two low complexity regions 
(often thought to be involved in trans-activation39 were either not required for trans-activation (the Alanine 
repeat region) or contributed a repressive influence (the Histidine repeat region). The ZIC3 trans-activation 
activity therefore localises to domains which are evolutionarily conserved amongst the Subclass A proteins, but 
lost from the Subclass B proteins. This is consistent with the inability of the Subclass B proteins to significantly 
trans-activate the isolated ZIC binding site, even when it is multimerised and the ZIC protein overexpressed, 
despite their ability to interact with the motif.
To determine how the ZIC proteins behave at loci bound during normal biology, a locus known to exhibit 
functional ZIC3 binding in embryonic stem (ES)  cells21 was incorporated into the same vector as used for 
the multimerised binding site. The sequence, derived from the proximal promoter of the murine Nanog gene, 
contains binding sites for other transcription factors (OCT4, SOX2, ESRRB and KLF4) and was first identified 
as a multiple transcription factor  locus40. ZIC3 is known to bind and stimulate Nanog transcription from this 
promoter region in conjunction with OCT4 and  SOX221. When incorporated into the ZIC trans-activation assay 
in HEK293T cells, ZIC3 activated this element at a similar level to that obtained in murine ES  cells21 whereas the 
ZIC3-C365S variant protein did not activate it, demonstrating the activity is dependent upon interaction with 
the reporter DNA. Both Subclass B proteins were able to activate this element in HEK293T cells, indicating that 
the co-location of other transcription factors at a DNA sequence can enable the Subclass B proteins to promote 
transcription, despite their inability to do so at an isolated ZIC binding site.
This context dependent activity of the ZIC proteins was investigated further using the same ZIC3 domain dele-
tion mapping approach as used with the multimerised binding site. Analysis revealed that many recognised ZIC 
domains exhibit different behaviour at the MTL element. For example, the SACC domain is required for maximal 
trans-activation at the multimerised binding site, but its removal does not significantly decrease transcription at 
the MTL. This suggests that interactions at the MTL can overcome the requirement for SACC as a trans-activator 
and that SACC is not required for these interactions. In contrast, removal of the SANC domain prevents some 
of the ZIC3 stimulated increase in trans-activation at the MTL indicative of a more robust requirement for this 
region. The three regions identified as necessary for transcriptional repression show altered activity at the MTL. 
Removal of ZOC or ZFNC does not elevate transcription at the MTL (as it does at the multimerised binding site) 
and removal of the Histidine repeat actually prevents some of the ZIC3 stimulated increase in trans-activation 
at the MTL. In each case, the repressive effect of these domains at the isolated ZIC3 binding site is prevented by 
interactions at the MTL. In a similar manner, the Alanine repeat domain (which plays no role in trans-activation 
per se) is necessary for optimal trans-activation at the MTL, indicative of a role in MTL interactions. This could 
account for the pathogenicity observed in human patients upon the expansion of this  domain41,42. The experi-
ments conducted here all use a loss-of-function (i.e. deletion) strategy that defines protein regions necessary for 
a given activity (in this case, trans-activation of reporter DNA). To determine whether any regions are sufficient 
for trans-activation, a gain-of-function assay is required (such as a GAL-4/UAS reporter assay). Furthermore, 
the experiments all rely on protein overexpression and it would be prudent to test the observations in a more 
physiological system.
The experiments reported here suggest that the overall transcriptional control ability of each ZIC protein is 
likely determined by their complement of domains that fall into three groups with respect to evolutionary con-
servation. First, a domain that is conserved amongst all family members (ZFNC), second, a domain whose type 
(i.e. low complexity region) is conserved in all ZIC proteins, but varies in number and composition and third, 
the Subclass A specific domains (ZOC, SANC and SACC). Some of these domains confer context dependent 
transcriptional behaviour and there is evidence that this is mediated by these regions acting as binding sites for 
protein  partners7,8 and/or as targets of post-translational  modifications43. Additionally, regions of low complex-
ity sequence are also associated with the ability to bind multiple proteins and fold into different structures upon 
binding and are thought to be accessible to post translational  modifications44. A picture therefore emerges of ZIC 
proteins with a ZFD flanked by regions of relative disorder. The flanking regions appear to participate in context 
specific interactions which ultimately determine the transcriptional outcome at a given ZRE. This flexibility is 
consistent with multiple proposed binding partners for the ZIC  proteins30,45–47 and multiple biological roles of 
each family member. This work significantly advances our understanding of how ZIC proteins differentially 
control transcription. It identifies domains necessary for trans-activation that are absent from Subclass B proteins 
and other protein regions that control context dependent transcriptional control. The work will assist studies 
that assess likely pathogenicity of variant ZIC proteins found in the human genome or that seek to identify the 
context specific factors that influence functional transcription factor binding of the ZIC proteins.
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Methods
plasmids. The generation of V5-DEST, V5-ZIC2-wt, V5-ZIC3-wt, V5-ZIC5-wt, V5-ZIC3-katun, V5-ZIC3-
C268X, V5-ZIC3-Q292X, V5-ZIC3-1507insTT and V5-ZIC3-K408X has been described  previously18, as has 
V5-ZIC2-C371S46. The APOE reporter construct (B:luc+:APOE) was a gift from Francisco Zafra (Centro de 
Biología Molecular, Universidad Autonoma de Madrid, Spain)17. pGL4.20 (B:luc2) was purchased from Promega 
(Cat No. E675A). The remaining plasmids were generated as follows.
Expression constructs. Expression constructs were created using the Gateway Recombination Cloning Tech-
nology (Life Technologies). An entry clone containing the protein of interest coding DNA sequence (CDS) was 
generated using the pENTR3C vector (Life Technologies). Expression plasmids were created by transferring the 
CDS to pcDNA3.1/nV5-DEST expression vector (Life Technologies).
pENTR3C-ZIC1-wt: full-length ZIC1 CDS was PCR amplified from pcDNA-ZIC1-wt (a gift from Kathleen 
Millen, Seattle Children’s Hospital Research Foundation, USA) and cloned into the EcoRI sites of pENTR3C 
(Life Technologies) using the In-Fusion Dry-Down PCR Cloning System (Clontech).
pENTR3C-ZIC4-wt: full-length ZIC4 CDS was cloned by PCR amplifying the first 213 bp of ZIC4-wt CDS 
from genomic DNA (of HEK293T cells), while the 214-1005 portion of ZIC4 was PCR amplified from pcDNA-
ZIC4-wt_214-1005 (a gift from Kathleen Millen, Seattle Children’s Hospital Research Foundation, USA). Full 
length ZIC4 CDS was created by joining these fragments in an overlap extension PCR and cloned into the EcoRI 
sites of pENTR3C (Life Technologies) using the In-Fusion Dry-Down PCR Cloning System (Clontech).
pENTR3C-ZIC5-C528S: Overlap extension PCR was used to introduce the C528S mutation within pEN-
TR3C-ZIC5-WT to generate pENTR3C-ZIC5-C528S.
pENTR3C-ZIC1-C339S, pENTR3C-ZIC3-E155X, pENTR3C-ZIC3-C268S, pENTR3C-ZIC3-C302S, pEN-
TR3C-ZIC3-C335S, pENTR3C-ZIC3-C365S, pENTR3C-ZIC3-C393S, and pENTR3C-ZIC4-C241S: mutations 
were created using the QuikChange Lightning Site-Directed Mutagenesis kit (Agilent Technologies; Cat. No. 
210518) according to manufacturer’s instructions.
pENTR3C-ZIC3-ZOCdel, pENTR3C-ZIC3-ZFNCdel, pENTR3C-ZIC3-Ndel, pENTR3C-ZIC3-Aladel, pEN-
TR3C-ZIC3-Hisdel, pENTR3C-ZIC3-SANCdel and pENTR3C-ZIC3-SACCdel: deletions mutants were made by 
Site-Directed Mutagenesis PCR. Mutagenesis PCRs were performed with the PfuUltra II Hotstart PCR Master 
Mix (Agilent Technologies; Cat. No. 600850) using 10 ng of pENTR3C-ZIC3-wt, according to manufacturer’s 
instructions. Following PCR, the amplified DNA was purified by ethanol precipitation and digested with DpnI 
enzyme (NEB; Cat. No. R0176) for 2 h. DNA was again purified by ethanol precipitation and transformed into 
E. coli. Bacterial colonies were screened for the correct plasmid via DNA sequencing.
All ‘Entry’ clones (pENTR3C) were transferred to the pcDNA3.1/nV5-DEST expression vector via a Gateway 
LR Clonase reaction (Life Technologies) to generate V5-ZIC1-wt, V5-ZIC1-C339S, V5-ZIC3-E155X, V5-ZIC3-
C268S, V5-ZIC3-C302S, V5-ZIC3-C335S, V5-ZIC3-C365S, V5-ZIC3-C393S, V5-ZIC4-C241S V5-ZIC3-ZOCdel, 
V5-ZIC3-ZFNC, V5-ZIC3-Ndel, V5-ZIC3-Aladel, V5-ZIC3-Hisdel, V5-ZIC3-SANCdel, V5-ZIC3-SACCdel, 
V5-ZIC4-wt, V5-ZIC4-C241S and V5-ZIC5-C528S.
Reporter constructs. B:luc2:β-globin, B:luc2:c-fos, B:luc2:TK: the β-globin promoter was PCR amplified from 
plasmid pKS:β-globin:lacZ48,the c-fos promoter was PCR amplified from TOPflash:c-fos plasmid (gift from Dr. 
Sabine Tejpar, Department of Oncology, Katholieke Universiteit Leuven, Belgium),the TK promoter was PCR 
amplified from TOPflash:TK plasmid (Upstate Biotechnology). Each amplicon was cloned into B:luc2 using 
HindIII sites.
B:luc2:APOE, B:luc2:APOE:β-globin, B:luc2:Nanog, B:luc2:Nanog:β-globin, B:luc2:Foxd3 and B:luc2:Foxd3:β-
globin: the APOE promoter region was PCR amplified from B:luc+:APOE; the Nanog promoter region was 
PCR amplified from mouse genomic DNA; the murine region equivalent to the chick Foxd3 ZIC1 responsive 
 enhancer49 was identified in RVista. The ZRE and flanking sequence (270 bp up- and down-stream) was PCR 
amplified from C57BL/6J genomic DNA. Each amplicon was cloned into B:luc2 and B:luc2:β-globin using KpnI 
and BglII sites.
B:luc2:Z3M2: the Z3M2 synthetic enhancer was constructed by using forward and reverse oligomers (Gene 
Link) that contained six repeats of Z3M2 (5′-CCC AGC GGG G-3′) separated by a 5-nucleotide spacer frag-
ment (5′-TAG AA-3′). Oligomers were mixed in a 1:1 molar ratio and diluted to a concentration of 1 pmol/µL 
in oligo annealing buffer [10 mM Tris (pH = 8.0), 0.1 mM EDTA, 50 mM NaCl]. Annealing was carried out in 
PCR Thermal Cycler using the following program: 95 °C for 5 min, followed by 1 °C/min decrease in tempera-
ture for 70 min. Annealed oligomers were purified by ethanol precipitation and cloned into B:luc2 using KpnI 
and HindIII sites.
B:luc2:Z3M2:β-globin: The β-globin promoter (PCR amplified using Ark1510_F and Ark1507_R) was cloned 
into B:luc2:Z3M2 vector using HindIII sites.
B:luc2:Z3mtt:β-globin: the vector was obtained spontaneously during routine plasmid propagation. The Z3M2 
site was mutated to 5′-CTA TCC CTG GGG GAG GGG GC-3′.
cell culture, transfection and western blotting. Cell culture, transfections and western blotting were 
performed as previously  described18. In each experiment the nuclear fraction was used to detect expression 
of the transfected ZIC proteins using α-V5 (1:3,000 dilution; Life Technologies, R960-25) and to assess equal 
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Luciferase assays. Luciferase assays were performed as previously  described18 with the following modifi-
cations. Approximately 2 × 105 cells, grown in flat bottom cell culture treated 12-well plates (Costar, CLS3513), 
were transfected with a total of 1.6 µg of DNA per well: 0.6 µg of reporter construct and either 1.0 µg of the 
expression construct or the negative control V5-DEST. 6 h post-transfection, cells were dissociated from the 
growth surface using 0.5 g/L trypsin (Life Technologies) and three replicate samples established by plating each 
transfection in triplicate on to a solid white tissue culture treated 96-well plate (Costar, CLS3917). 18 h after re-
plating, cells in each well were lysed by incubation with 100 µL of a 1:1 dilution of luciferase substrate (ONE-Glo 
Luciferase Assay System, Promega) with Dulbecco’s Modified Eagle’s Medium (DMEM: Life Technologies) and 
the luminescence from each well measured using a TECAN Infinite M1000 Pro.
For each data point, the luciferase activity was normalised to the respective negative control V5-DEST lucif-
erase value (such that the V5-DEST value becomes 1) to determine a relative luciferase activity: RLA. Follow-
ing normalisation, the mean RLA and standard deviation (SD) was calculated from the three replicates (using 
Microsoft Excel). Each transfection was repeated three independent times (denoted by N) and the overall data 
set analysed as described under Statistical Analysis below.
pip-qpcR. HEK293T cells, grown in 100 mm TC dishes (Sigma-Aldrich; CLS430167) were transfected with 
8 μg of the B:luc2:Z3M2 reporter construct or the negative control empty vector backbone pGL4.20 (B:luc2) and 
16 μg of V5-ZIC-wt or V5-ZIC-variant construct. Six hours post-transfection, cells were dissociated from the 
growth surface using 0.5 g/L trypsin and plated in 150 mm TC dishes (Iwaki; 3030-150). 24 h post-transfection, 
media was removed and protein-DNA complexes cross-linked with 1.25% formaldehyde (w/v) (Sigma-Aldrich; 
F8775) at room temperature for 10  min. Cross-linking was terminated by the addition of 125  mM Glycine 
(Amresco; Cat. No. 0167) and cells washed thrice with ice-cold 1 × PBS. Cells were scraped in ice-cold 1 × PBS 
containing 0.02% Tween20 (Sigma-Aldrich; P7949) and pelleted via centrifugation. The pellet was resuspended 
in 1.8 mL of sonication buffer [50 mM Hepes (pH 7.9), 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% 
Na-deoxycholate, 0.1% SDS and protease inhibitors (AEBSF and PMSF)]. Cells were sonicated to obtain an aver-
age chromatin length of 500 bp using the Bioruptor (Diagenode) at 4 °C. To separate cellular debris sonicated 
samples were centrifuged (18,000g, 5 min, 4 °C).
Chromatin was pre-cleared with a 1:1 mixture of protein A (Novex; 10001D) and protein G (Novex; 10003D) 
Dynabeads for 2 h at 4 °C on a rotating platform. Pre-cleared chromatin was incubated with 7 μg of α-V5 
antibody (Abcam; ab9116) in sonication buffer with protease inhibitors (rotating overnight, 4 °C). The follow-
ing day, beads were washed at 4 °C once with ice-cold sonication buffer (with protease inhibitors) and thrice 
with sonication buffer containing 500 mM NaCl (with protease inhibitors), followed by one wash with ice-cold 
Lithium Chloride (LiCl) buffer (250 mM LiCl, 10 mM Tris–HCl (pH 8.0), 1 mM EDTA, 0.5% NP-40 and 0.5% 
Na-deoxycholate) and two washes with TE (10 mM Tris–HCl (pH 8.0), 1 mM EDTA). Beads were resuspended 
in 91.5 μL of TE and treated with 0.5 μg of RNase A (Thermo Fisher Scientific; Cat. No. EN0531) at 37 °C for 
30 min. Cross-links were reversed by adding 5 μL of 10% SDS and 50 μg of Proteinase K (Thermo Fisher Sci-
entific; Cat. No. EO0491) and incubation at 65 °C for 5 h. DNA was extracted using the AMPure purification 
system (according to manufacturer’s protocol).
qPCR was performed using 1 μL of a 1:10 dilution of input (10%) or pIP-enriched DNA, ImmoMix (Bioline; 
Cat. No. BIO-25020), 0.5 μM Ark1566_F (5′-CAT TTC TCT GGC CTA ACT GG-3′) and Ark1567_R (5′-AAC AGT 
ACC GGA TTG CCA AG-3′) primers, and SYBR Green dye in a 10 μL volume. PCRs were run using the StepOne 
Real-time PCR machine (Applied Biosystems) with the following PCR cycling conditions: 95 °C for 5 min, fol-
lowed by 40 cycles of 95 °C for 15 s, 55 °C for 20 s and 72 °C for 30 s and a melt curve stage that included 95 °C 
for 15 s, 55 °C for 1 min and 0.3 °C increase in temperature every 15 s until it reached 95 °C. Data was analysed 
using the StepOne Software (v2.3). The amount of target-specific DNA precipitated was determined relative to 
the amount of non-immunoprecipitated (input) DNA, using the percent input method as outlined on: https ://
www.therm ofish er.com/au/en/home/life-scien ce/epige netic s-nonco ding-rna-resea rch/chrom atin-remod eling /
chrom atin-immun oprec ipita tion-chip/chip-analy sis.html.
Statistical analysis. Luciferase assays: A two-way analysis of variance (ANOVA) on raw luminescence data 
pooled from three independent repeat transfections was performed via Genstat. The mean and a single experi-
mental Standard Error of the Mean (SEM) was calculated for all treatment groups. The same operation per-
formed to calculate the RLA was used to calculate a normalised SEM value i.e. normalised SEM values for RLA 
were calculated by dividing the SEM of raw luminescence values by the mean luminescence value of V5-DEST 
from three experimental repeats. A Post Hoc test using the Bonferroni correction method (α = 0.01) was per-
formed to identify treatment groups that were significantly different. When the difference between means of two 
treatment groups was larger than the computed Least Significant Difference (LSD), the treatments were consid-
ered significantly different. The software assigned a unique letter (a, b, c, d, e…) to the treatment group that was 
significantly different from all other treatments. When the difference between means of two treatment groups 
was less than the LSD, they were assigned the same letter indicating no significant difference.
pIP-qPCR: Excel was used to perform a t-Test (one-tailed) on the mean percent input values.
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